Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Meda Snaps Up Sequoia-Backed Acton Pharmaceuticals for $135M+ 08/30/13 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
NEA, Genzyme Join $18M Round For Rare Disease Startup Edimer 07/30/13 Boston
Aegerion Shares Soar on New Numbers For Rare Disease Drug 07/30/13 Boston
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Biogen’s Oral MS Drug Tops Estimates, Brings in $192M in First Quarter 07/25/13 Boston
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
Alnylam’s Amyloidosis Drug Holds up in Second Clinical Trial 07/01/13 Boston
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
PTC Therapeutics IPO Raises $125M Despite Checkered Past 06/20/13 New York
Amicus Shelves New-Drug Filing For Fabry Disease Drug 06/17/13 New York
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
There’s Less Pie in the Sky as Wireless Health Gets Connected 05/30/13 San Diego
Merrimack Aims For Penny-Wise Pipeline of Cancer Drugs 05/24/13 Boston
Regeneron Eyes Potential Blockbuster With Asthma Drug 05/21/13 New York
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) 05/14/13 National
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Fighting a Global War on Rare Diseases 03/20/13 New York
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Veracyte Wins Over UnitedHealth With Thyroid Cancer Diagnostic 03/08/13 San Francisco
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
Page 2 of 4 « previous page · next page »